HANNAH CRAVEN: Open Payments
NPI 1003410754 · WESTMINSTER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 26 payments from 14 companies in 2025. Trend: 2023 $184 · 2024 $101 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $219 |
| Madrigal Pharmaceuticals | 1 | $135 |
| Novo Nordisk Inc | 2 | $97 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| Lilly USA, LLC | 2 | $47 |
| ABBVIE INC. | 2 | $37 |
| Dexcom, Inc. | 1 | $31 |
| Exact Sciences Corporation | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $25 |
Products named: AIRSUPRA, REZDIFFRA, Wegovy, SHINGRIX, MOUNJARO, Kerendia, QULIPTA, Dexcom G6 Transmitter.
Industry payments across CO — which companies pay providers there.
